Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia
- Conditions
- Cancer of ProstateInsomnia
- Interventions
- Behavioral: 12-week aerobic exercise and cognitive-behavioral therapy
- Registration Number
- NCT03444532
- Lead Sponsor
- Danish Cancer Society
- Brief Summary
This study of a randomized controlled trial aims to evaluate the feasibility of a 12-week sleep program and the randomized controlled trial research procedure. In total 20 participants will be recruited and randomized to the intervention or control group.
- Detailed Description
This feasibility study of a randomized controlled trial, aims to evaluate the feasibility of a 12-week sleep program consisting on aerobic exercise and cognitive-behavioral therapy. In this study the investigators wish to evaluate the program as well as the randomized controlled trial research procedure.
In total 20 participants will be recruited and randomized to either the intervention group (n=10) or control group (n=10).The intervention group will participate in two exercise sessions each week and four sessions based on cognitive-behavioral therapy for insomnia.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
- Prostate cancer
- Receiving treatment with androgen deprivation therapy or in combination with chemotherapy
- Insomnia
- Over 18-yers old
- Understand oral and written Danish
- Written informed consent
- Medical assessment that does not allow aerobic exercise
- Severe cognitive problems
- Night work during the interventions period
- Exercise training more than three times a week
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 12-week aerobic exercise and cognitive-behavioral therapy 12-week aerobic exercise and cognitive-behavioral therapy 12-week aerobic exercise, two times per week, and cognitive-behavioral therapy for insomnia in total four sessions
- Primary Outcome Measures
Name Time Method Sleep Change from baseline sleep at 12 weeks Measured by actigraphy, to investigate change in sleep from baseline to 12 weeks and the difference in change between intervention - and the control group
- Secondary Outcome Measures
Name Time Method Quality of life Baseline, 12 weeks, 6 month Measured by European Organization for Research and Treatment Cancer, to investigate change in quality of life from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Stress Baseline, 12 weeks, 6 month Measured by Perceived Stress Scale to investigate change in stress from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Physical activity Baseline, 12 weeks Measured by actigraphy, to investigate change in physical activity from baseline to 12 weeks and the difference in change between intervention - and the control group
Insomnia Baseline, 12 weeks, 6 month Measured by Insomnia Severity Index, to investigate change in insomnia from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Fatigue Baseline, 12 weeks, 6 month Measured by the multidimensional fatigue inventory, to investigate change in fatigue from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Depression Baseline, 12 weeks, 6 month Measured by the Patient Health Questionnaireto, to investigate change in depression from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Cardiorespiratory fitness Baseline, 12-weeks Measured by watt max test, to investigate change from baseline to 12 weeks and the difference in change between intervention and the control group
Anxiety Baseline, 12 weeks, 6 month Measured by the Generalized Anxiety Disorder Questionnaireto, to investigate change in anxiety from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Sleep quality Baseline, 12 weeks, 6 month Measured by Pittsburgh Sleep Quality Index, to investigate change in sleep quality from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Sleep pattern Baseline, 12 weeks, 6 month Measured by a sleep diary, to investigate change in sleep pattern from baseline to 12 weeks and 6 months follow up and the difference in change between intervention - and the control group
Trial Locations
- Locations (1)
Oncology Department
🇩🇰Næstved, Denmark